121
Views
1
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLES

Bacterial Melanin Improves Cognitive Impairment Induced by Cerebral Hypoperfusion in Rats

&
Pages 469-475 | Received 10 Dec 2013, Accepted 18 Jul 2014, Published online: 16 Sep 2014

REFERENCES

  • Aliev, G., Smith, M. A., Obrenovich, M. E., de la Torre, J. C., & Perry, G. (2003). Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease. Neurotoxicity Research, 5, 491–504.
  • Aronsson, A. F., Spulber, S., Popescu, L. M., Winblad, B., Post, C., Oprica, M., & Schultzberg, M. (2006). A-melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides, 40, 65–75.
  • Azaryan, K. G., Petrosyan, M. T., Popov, Y. G., & Martirosyan, G. S. (2004). Melanin in the agriculture and dendrology. Bulletin of the Armenian Agricultural Academy, 4, 7–10.
  • Bharne A. P., Upadhya, M. A., Kokare, D. M., & Subhedar, N. K. (2011). Effect of alpha-melanocyte stimulating hormone on locomotor recovery following spinal cord injury in mice: role of serotonergic system. Neuropeptides, 45, 25–31.
  • Chen, G., Frøkiær, J., Pedersen, M., Nielsen, S., Si, Z., Pang, Q., & Stødkilde-Jørgensen, H. (2008). Reduction of ischemic stroke in rat brain by alpha melanocyte stimulating hormone. Neuropeptides, 42, 331–338.
  • De la Torre, J. C., & Aliev, G. (2005). Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: Spatial memory and immunocytochemical changes. Journal of Cerebral Blood Flow Metabolism, 25, 663–672.
  • Fanardjian, V. V., Gevorkyan, O. V., Mallina, R. K., Melik-Musyan, A. B., & Meliksetyan, I. B., (2001). Dynamics of changes in operant reflexes in rats after transection of thecorticospinaltract and extirpation of the sensorimotor area of the cerebral cortex. Rossiĭskii fiziologicheskiĭ zhurnal, 87, 145–154.
  • Farkas, E., de Wilde, M. C., Kiliaan, A. J., & Luiten, P. G. (2002). Chronic cerebral hypoperfusion-related neuropathologic changes and compromised cognitive status: window of treatment. Drugs of Today (Barcelona), 38, 365–376.
  • Farkas, E., Institoris, A., Domoki, F., Mihaly, A., Luiten, P. G., & Bari, F. (2004).Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Research, 1008, 252–260.
  • Gevorkyan, O. V., Meliksetyan, I. B., Hovsepyan, A. S., & Sagiyan, A. S. (2007). Effects of BT-melanin on recovery of operant conditioned reflexes in rats after ablation of the sensorimotor cortex. Neuroscience and Behavioral Pyschology, 37, 471–476.
  • Mann, D. M., Yates, P. O., & Marcyniuk, B. (1984). Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mechanisms of Ageing and Development, 25, 189–204.
  • Manvelyan, L. R., Petrosyan, T. R., & Gevorkyan, O. V. (2010). About factors that alter plasticity in nervous system after corticospinal tract lesions. National Academy Reports, 110, 302–307.
  • Micieli, G. (2006). Vascular dementia. Neurological Sciences, 27, 37–39.
  • Morris, R. G. (1984). Developments of water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods, 11, 47–60.
  • Petrosyan, T. R., Gevorkyan, O. V., Chavushyan, V. A., Meliksetyan, I. B., Hovsepyan, A. S., & Manvelyan, L. R. (2014). Effects of bacterial melanin on motor recovery and regeneration after unilateral destruction of Substantia Nigra pars compacta in rats. Neuropeptides, 48, 37–46.
  • Petrosyan, T. R., Gevorkyan, O. V., Meliksetyan, I. B., Hovsepyan, A. S., & Manvelyan, L. R. (2012). The action of bacterial melanin in rats after pyramidal tract lesions. Journal of Pathophysiology, 19, 71–80.
  • Proctor, P. H. (1989). Free radicals and human disease: A review. In Jaime Miquel (Ed.), CRC handbook of free radicals and antioxidants (vol. 1, pp. 209–221). Boca Raton, FL: CRC Press.
  • Proctor, P. H., & Reynolds, E. S. (1984). Free radicals and disease in man. Physiological Chemistry and Physics, 16, 175.
  • Rampersaud, N., Harkavyi, A., Giordano, G., Lever, R., Whitton, J., & Whitton, P. S. (2012). Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit. British Journal of Pharmacology, 167, 1467–1479.
  • Reglödi, D., Lubics, A., Kiss, P., Lengvári, I., Gaszner, B., Tóth, G., … Tamás, A. (2006). Effect of PACAP in 6-OHDA-induced injury of the Substantia Nigra in intact young and ovariectomized female rats. Neuropeptides, 40, 265–274.
  • Sarkissian, J. S., Galoyan, A. A., Kamalyan, R. G., Chavushyan, V. A., Meliksetyan, I. B., Poghosyan, M. V., … Manucharyan, M. K. (2007). The effect of bacterial melanin on electrical activity of neurons of the Substantia Nigra under conditions of GABA generation. Neurochemical Journal, 1, 227–234.
  • Sarna, T. (1992). Properties and function of the ocular melanin: A photobiophysical view. Journal of Photochemistry and Photobiology, 12, 215–258.
  • Tsuchiya, M., Sako, K., Yura, S., & Yonemasu, Y. (1993). Local cerebral glucose utilization following acute and chronic bilateral carotid artery ligation in Waster rats: relation to changes in local cerebral blood flow. Experimental Brain Research, 95, 1–7.
  • Tupper, D. E., & Wallace, R. B. (1980). Utility of the neurological examination in rats. Acta Neurobiologiae Experimentalis, 40, 999–1003.
  • Wang, Z. F., Wang, J., Zhang, H. Y., & Tang, X. C. (2008). Huperzine A exhibits anti-inflammatory and neuroprotective effects in a rat model of transient focal cerebral ischemia. Journal of Neurochemistry, 106(4), 1594–1603.
  • Zecca, L. (2002). The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Letters, 16, 216–220.
  • Zecca, L., Tampellini, D., Gerlach, M., Riederer, P., Fariello, R. G., & Sulzer, D. (2001). Substantia nigra neuromelanin: Structure, synthesis, and molecular behaviour. Journal of Clinical Pathology: Molecular Pathology, 54, 414–418.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.